Works matching DE "INSULIN antibodies"


Results: 419
    1
    2
    3
    4
    5
    6

    Dietary insulin as an immunogen and tolerogen.

    Published in:
    Pediatric Allergy & Immunology, 2006, v. 17, n. 7, p. 538, doi. 10.1111/j.1399-3038.2006.00447.x
    By:
    • Tiittanen, Minna;
    • Paronen, Johanna;
    • Savilahti, Erkki;
    • Virtanen, Suvi M.;
    • Ilonen, Jorma;
    • Knip, Mikael;
    • Åkerblom, Hans K.;
    • Vaarala, Outi
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Polymorphism in the sorbin and SH3-domain-containing-1 (SORBS1) gene and the risk of brain infarction in the Japanese population: the Fukuoka Stroke Registry and the Hisayama study.

    Published in:
    European Journal of Neurology, 2008, v. 15, n. 5, p. 481, doi. 10.1111/j.1468-1331.2008.02105.x
    By:
    • Hagiwara, N.;
    • Kitazono, T.;
    • Kamouchi, M.;
    • Kuroda, J.;
    • Ago, T.;
    • Hata, J.;
    • Ninomiya, T.;
    • Ooboshi, H.;
    • Kumai, Y.;
    • Yoshimura, S.;
    • Tamaki, K.;
    • Fujii, K.;
    • Nagao, T.;
    • Okada, Y.;
    • Toyoda, K.;
    • Nakane, H.;
    • Sugimori, H.;
    • Yamashita, Y.;
    • Wakugawa, Y.;
    • Kubo, M.
    Publication type:
    Article
    23
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Immunogenicity, efficacy, and safety of biosimilar insulin glargine (Gan & Lee glargine) compared with originator insulin glargine (Lantus®) in patients with type 2 diabetes after 26 weeks' treatment: A randomized open label study.

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 6, p. 2412, doi. 10.1111/dom.15560
    By:
    • Christofides, Elena A.;
    • Puente, Orlando;
    • Norwood, Paul;
    • Denham, Douglas;
    • Maheshwari, Hiralal;
    • Lillestol, Michael;
    • Hart, Terence;
    • Nakhle, Samer;
    • Chadha, Anurekha;
    • Fitz‐Patrick, David;
    • Sugimoto, Danny;
    • Soufer, Joseph;
    • Young, Douglas;
    • Warren, Mark;
    • Huffman, David;
    • Reed, John;
    • Bays, Harold;
    • Arora, Samir;
    • Rizzardi, Barbara;
    • Tidman, Raymond
    Publication type:
    Article
    46
    47

    A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes.

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1111, doi. 10.1111/dom.14010
    By:
    • Curtin, Francois;
    • Champion, Bernard;
    • Davoren, Peter;
    • Duke, Sally;
    • Ekinci, Elif I.;
    • Gilfillan, Chris;
    • Morbey, Claire;
    • Nathow, Thomas;
    • O'Moore‐Sullivan, Trisha;
    • O'Neal, David;
    • Roberts, Adam;
    • Stranks, Stephen;
    • Stuckey, Bronwyn;
    • Vora, Parind;
    • Malpass, Sam;
    • Lloyd, David;
    • Maëstracci‐Beard, Nicole;
    • Buffet, Bénédicte;
    • Kornmann, Gabrielle;
    • Bernard, Corinne
    Publication type:
    Article
    48
    49
    50